Annexon, Inc. (ANNX)
NASDAQ: ANNX · IEX Real-Time Price · USD
5.67
+0.04 (0.71%)
Jul 22, 2024, 10:34 AM EDT - Market open
Annexon Employees
Annexon had 71 employees as of December 31, 2023. The number of employees decreased by 9 or -11.25% compared to the previous year.
Employees
71
Change (1Y)
-9
Growth (1Y)
-11.25%
Revenue / Employee
n/a
Profits / Employee
-$1,700,521
Market Cap
604.02M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71 | -9 | -11.25% |
Dec 31, 2022 | 80 | 19 | 31.15% |
Dec 31, 2021 | 61 | 13 | 27.08% |
Dec 31, 2020 | 48 | 24 | 100.00% |
Dec 31, 2019 | 24 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Varex Imaging | 2,400 |
Emergent BioSolutions | 1,600 |
Adaptive Biotechnologies | 709 |
Surmodics | 376 |
Allogene Therapeutics | 233 |
Larimar Therapeutics | 42 |
ANNX News
- 5 days ago - Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting - GlobeNewsWire
- 26 days ago - Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting - GlobeNewsWire
- 4 weeks ago - Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Annexon Announces Pricing of $125 Million Underwritten Public Offering - GlobeNewsWire
- 6 weeks ago - Annexon Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Annexon's neurological disorder drug meets main goal of late-stage study - Reuters
- 6 weeks ago - Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data - GlobeNewsWire